{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:06:16Z","timestamp":1794002776164,"version":"4.8.0"},"reference-count":41,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>In unrelated allogeneic hematopoietic cell transplantation (allo-HCT), older and\/or HLA-mismatched donors are known risk factors for survival outcomes. In healthy individuals, cytomegalovirus (CMV) seropositivity is associated with impaired adaptive immune systems. We assessed whether the adverse effects of donor risk factors are influenced by the donor CMV serostatus. We analyzed 5836 patients with CMV seropositivity who received unrelated allo-HCT. We divided the entire cohort into 2 cohorts according to the donor CMV serostatus: CMV positive (DP) and negative (DN). We also stratified each cohort into 4 groups based on donor age (aged \u226540 or &amp;lt;40 years) and HLA parity (8\/8 or 7\/8): Young88 and Old88, and Young78 and Old78, respectively. In the CMV-DP cohort, the Old88 (hazard ratio [HR], 1.20; P = .012), Young78 (HR, 1.35; P &amp;lt; .001), and Old78 (HR, 1.60; P &amp;lt; .001) groups were associated with inferior overall survival (OS) than the Young88 group. In contrast, in the CMV-DN cohort, neither donor age nor HLA disparity was associated with inferior OS. The adverse impact of donor age was different between the cohorts (CMV-DP: HR, 1.19; P = .001; CMV-DN: HR, 1.04; P = .53; P for interaction, .070), as was the impact of HLA (CMV-DP: HR, 1.34; P &amp;lt; .001; CMV-DN: HR, 1.08; P = .23; P for interaction, .012). The impacts of donor age and HLA mismatch on OS might differ according to the donor CMV serostatus. In unrelated allo-HCT from a CMV-seronegative donor, an HLA-mismatched older donor may be able to be selected without affecting OS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024014408","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T16:59:25Z","timestamp":1736873965000},"page":"2356-2365","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7844-9233","authenticated-orcid":false,"given":"Shunto","family":"Kawamura","sequence":"first","affiliation":[{"name":"1Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan"},{"name":"2Division of Emerging Medicine for Integrated Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daishi","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9959-2955","authenticated-orcid":false,"given":"Takashi","family":"Nagayama","sequence":"additional","affiliation":[{"name":"4Division of Cell Transplantation and Transfusion, Jichi Medical University, Shimotsuke, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5054-9104","authenticated-orcid":false,"given":"Yuta","family":"Katayama","sequence":"additional","affiliation":[{"name":"5Department of Hematology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-3179","authenticated-orcid":false,"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[{"name":"6Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Takeda","sequence":"additional","affiliation":[{"name":"7Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Nishida","sequence":"additional","affiliation":[{"name":"8Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"9Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3976-5230","authenticated-orcid":false,"given":"Takashi","family":"Ikeda","sequence":"additional","affiliation":[{"name":"10Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ohigashi","sequence":"additional","affiliation":[{"name":"11Department of Hematology, Hokkaido University Hospital, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Sawa","sequence":"additional","affiliation":[{"name":"12Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8003-2584","authenticated-orcid":false,"given":"Kentaro","family":"Fukushima","sequence":"additional","affiliation":[{"name":"13Department of Hematology and Oncology, Osaka University Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-3633","authenticated-orcid":false,"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Serizawa","sequence":"additional","affiliation":[{"name":"14Division of Hematology and Rheumatology, Department of Internal Medicine, Kindai University Hospital, Osakasayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Onizuka","sequence":"additional","affiliation":[{"name":"15Department of Hematology\/Oncology, Tokai University School of Medicine, Isehara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[{"name":"7Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-2870","authenticated-orcid":false,"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[{"name":"16Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan"},{"name":"17Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan"},{"name":"18Division of Hematology, Jichi Medical University, Shimotsuke, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-9315","authenticated-orcid":false,"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan"},{"name":"2Division of Emerging Medicine for Integrated Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"issue":"3","key":"2025051311215354800_bib1","first-page":"271","article-title":"Hematopoietic cell transplantation in Japan a report from a nationwide survey in 2023","volume":"59","author":"The Japanese Data Center for Hematopoietic Cell Transplantation","year":"2024","journal-title":"Jpn J Transplant"},{"issue":"6","key":"2025051311215354800_bib2","doi-asserted-by":"crossref","first-page":"346.e1","DOI":"10.1016\/j.jtct.2023.03.007","article-title":"Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant Research","volume":"29","author":"Auletta","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"2025051311215354800_bib3","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"2025051311215354800_bib4","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1038\/s41409-021-01431-6","article-title":"Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group","volume":"56","author":"Xu","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2025051311215354800_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"2025051311215354800_bib6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","article-title":"The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy","volume":"127","author":"Kollman","year":"2016","journal-title":"Blood"},{"issue":"7","key":"2025051311215354800_bib7","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","article-title":"Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age","volume":"98","author":"Kollman","year":"2001","journal-title":"Blood"},{"issue":"10","key":"2025051311215354800_bib8","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1038\/s41409-021-01289-8","article-title":"Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation","volume":"56","author":"Seo","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"2025051311215354800_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-030-02278-5_12","volume-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies","author":"Ayuk","year":"2019"},{"issue":"12","key":"2025051311215354800_bib10","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"},{"issue":"4","key":"2025051311215354800_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu364","article-title":"Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation","volume":"59","author":"Ljungman","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2025051311215354800_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41590-018-0049-7","article-title":"Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors","volume":"19","author":"Patin","year":"2018","journal-title":"Nat Immunol"},{"key":"2025051311215354800_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.exger.2016.02.005","article-title":"Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: a systematic review","volume":"77","author":"Weltevrede","year":"2016","journal-title":"Exp Gerontol"},{"key":"2025051311215354800_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fimmu.2013.00271","article-title":"Human T cell aging and the impact of persistent viral infections","volume":"4","author":"Fulop","year":"2013","journal-title":"Front Immunol"},{"issue":"3","key":"2025051311215354800_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1532\/IJH97.06239","article-title":"Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP system","volume":"86","author":"Atsuta","year":"2007","journal-title":"Int J Hematol"},{"issue":"3","key":"2025051311215354800_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2025051311215354800_bib17","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2025051311215354800_bib18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"24","key":"2025051311215354800_bib19","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1182\/blood.2023023697","article-title":"Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT","volume":"143","author":"Sanz","year":"2024","journal-title":"Blood"},{"issue":"28","key":"2025051311215354800_bib20","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1200\/JCO.24.00184","article-title":"Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis attenuates disparity in outcomes between use of matched or mismatched unrelated donors","volume":"42","author":"Shaffer","year":"2024","journal-title":"J Clin Oncol"},{"issue":"12","key":"2025051311215354800_bib21","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.bbmt.2018.06.026","article-title":"Relative impact of HLA matching and non-HLA donor characteristics on outcomes of allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome","volume":"24","author":"Ayuk","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2025051311215354800_bib22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/bmt.2016.352","article-title":"Recipient\/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants","volume":"52","author":"Shaw","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2025051311215354800_bib23","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41409-020-01178-6","article-title":"Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study","volume":"56","author":"Beauvais","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2025051311215354800_bib24","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbmt.2009.02.009","article-title":"Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation","volume":"15","author":"Nakamae","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2025051311215354800_bib25","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1182\/blood-2007-01-069294","article-title":"Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis","volume":"110","author":"Marty","year":"2007","journal-title":"Blood"},{"issue":"25","key":"2025051311215354800_bib26","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"issue":"8000","key":"2025051311215354800_bib27","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41586-023-06968-8","article-title":"Smoking changes adaptive immunity with persistent effects","volume":"626","author":"Saint-Andre","year":"2024","journal-title":"Nature"},{"issue":"26","key":"2025051311215354800_bib28","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1182\/blood.2020009492","article-title":"CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant","volume":"138","author":"Yeh","year":"2021","journal-title":"Blood"},{"issue":"1","key":"2025051311215354800_bib29","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1038\/s41467-022-29943-9","article-title":"Immunoprofiling reveals cell subsets associated with the trajectory of cytomegalovirus reactivation post stem cell transplantation","volume":"13","author":"Stern","year":"2022","journal-title":"Nat Commun"},{"issue":"11","key":"2025051311215354800_bib30","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.bbmt.2015.07.019","article-title":"Cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation is associated with a reduced risk of relapse in patients with acute myeloid leukemia who survived to day 100 after transplantation: the Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group","volume":"21","author":"Takenaka","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2025051311215354800_bib31","doi-asserted-by":"crossref","first-page":"683.e1","DOI":"10.1016\/j.jtct.2021.04.024","article-title":"Prediction of cytomegalovirus reactivation by recipient cytomegalovirus-IgG titer before allogeneic hematopoietic stem cell transplantation","volume":"27","author":"Kawamura","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"2025051311215354800_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"issue":"6","key":"2025051311215354800_bib33","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10096-020-03814-x","article-title":"Thirty years of CMV seroprevalence-a longitudinal analysis in a German University Hospital","volume":"39","author":"Hoehl","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"2025051311215354800_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jcv.2013.12.013","article-title":"Changes in cytomegalovirus seroprevalence in pregnant Japanese women-a 10-year single center study","volume":"59","author":"Taniguchi","year":"2014","journal-title":"J Clin Virol"},{"issue":"10","key":"2025051311215354800_bib35","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/trf.12390","article-title":"Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors","volume":"53","author":"Furui","year":"2013","journal-title":"Transfusion"},{"issue":"11","key":"2025051311215354800_bib36","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1086\/652438","article-title":"Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004","volume":"50","author":"Bate","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2025051311215354800_bib37","doi-asserted-by":"crossref","first-page":"521.e1","DOI":"10.1016\/j.jtct.2023.04.023","article-title":"Cytomegalovirus infection post-allogeneic stem cell transplantation: experience from a country with high seropositivity","volume":"29","author":"Iftikhar","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"2025051311215354800_bib38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00277-011-1351-8","article-title":"Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus","volume":"91","author":"Liu","year":"2012","journal-title":"Ann Hematol"},{"issue":"3","key":"2025051311215354800_bib39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.diagmicrobio.2018.12.017","article-title":"Evaluation of the Abbott ARCHITECT cytomegalovirus IgM\/IgG, rubella IgM\/IgG, and syphilis treponemal antibodies enzyme immunoassays in a mother and child health center population","volume":"94","author":"Grandjean Lapierre","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"2025051311215354800_bib40","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/JCM.02172-08","article-title":"Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays","volume":"47","author":"Lagrou","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"6","key":"2025051311215354800_bib41","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1128\/jcm.24.6.998-1003.1986","article-title":"Detection of immunoglobulin G antibodies to cytomegalovirus antigens by antibody capture enzyme-linked immunosorbent assay","volume":"24","author":"Nielsen","year":"1986","journal-title":"J Clin Microbiol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/9\/2356\/2374071\/blooda_adv-2024-014408-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/9\/2356\/2374071\/blooda_adv-2024-014408-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T11:22:07Z","timestamp":1747135327000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/9\/2356\/535058\/Impacts-of-donor-age-and-HLA-mismatch-on-HCT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,5,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024014408","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]}}}